Next-generation sequencing of vertebrate experimental organisms by Turner, Daniel J. et al.
REVIEW
Next-generation sequencing of vertebrate experimental organisms
Daniel J. Turner Æ Thomas M. Keane Æ
Ian Sudbery Æ David J. Adams
Received: 25 February 2009/Accepted: 21 April 2009/Published online: 19 May 2009
 The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Next-generation sequencing technologies are
revolutionizing biology by allowing for genome-wide
transcription factor binding-site proﬁling, transcriptome
sequencing, and more recently, whole-genome resequenc-
ing. While it is currently not possible to generate complete
de novo assemblies of higher-vertebrate genomes using
next-generation sequencing, improvements in sequence
read lengths and throughput, coupled with new assembly
algorithms for large data sets, will soon make this a reality.
These developments will in turn spawn a revolution in how
genomic data are used to understand genetics and how
model organisms are used for disease gene discovery. This
review provides an overview of the current next-generation
sequencing platforms and the newest computational tools
for the analysis of next-generation sequencing data. We also
describe how next-generation sequencing may be applied in
the context of vertebrate model organism genetics.
Introduction
When the Sanger (Sanger and Coulson 1975; Sanger et al.
1977) and Gilbert labs (Maxam and Gilbert 1977) ﬁrst
developed DNA sequencing, they would have been unlikely
to have predicted the revolution that has ensued. Nowadays,
rather than a sequencing experiment generating a single
DNA sequence read of modest length taking days, millions
of sequence reads, each several hundred base pairs in
length, can be generated in a single experiment. From
modest beginnings, with the ﬁrst experimental organism
sequenced being the phage /X174 (Sanger et al. 1978),
progress has been inexorable with the sequence of viruses,
including the human cytomegalovirus, following shortly
afterward (Kouzarides et al. 1983, 1987), then numerous
bacteria, with the human genome (Lander et al. 2001) and
then the mouse (Waterston et al. 2002) being the ﬁrst ver-
tebrate genomes sequenced. The sequence of rat followed
some years later (Gibbs et al. 2004). The Ensembl genome
browser (Hubbard et al. 2009) now displays annotated
genomes for 41 vertebrates. Apart from the human and
mouse genomes, which were sequenced as part of an
international consortium involving many sequencing cen-
tres, the majority of these genomes were sequenced by the
Broad Institutes’ Mammalian Genome Project (www.broad.
mit.edu/node/296). The genomes displayed in Ensembl
vary greatly in their quality and coverage, with many
sequenced to just 29 coverage. Although these genomes
represent a fabulous resource for comparative analysis, to
make them a universal resource and to maximise their
utility complete genome sequences are needed. In addition,
to fully understand genome function and evolution, the
complete sequence of multiple individuals or strains within
a species will be required. In humans such an endeavour has
already commenced, ﬁrst with the publication of the com-
plete genomes of four individuals (Bentley et al. 2008; Levy
et al. 2007; Wang et al. 2008; Wheeler et al. 2008), and now
with the 1000 genomes project (www.1000genomes.org),
which is using next-generation sequencing to generate a
high-resolution proﬁle of genomic variation. Furthermore,
The Mouse Genomes Project(www.sanger.ac.uk/modelorgs/
mousegenomes) is in the process of sequencing the gen-
omes of 17 key mouse strains. Indeed, while comparing
genomes across the animal kingdom is a powerful way of
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ing the identiﬁcation of functionally relevant genomic
regions, the evolutionary distance between organisms can
make such comparisons difﬁcult to interpret, particularly
for subtle or quantitative phenotypes. This makes the gen-
eration and collation of sequence data from individuals or
strains within a species desirable. Next-generation sequenc-
ing technologies are revolutionizing these sequence-gath-
ering efforts and helping to obtain reference sequence for
additional species such as Gorilla and Mammoth (Miller
et al. 2008).
Signiﬁcant efforts such as the collaborative cross
(Churchill et al. 2004) and the heterogeneous stock cross
(Solberg et al. 2006; Valdar et al. 2006) have been
undertaken to generate genetically diverse mouse resources
for complex trait analysis. Similar experiments are under-
way in rat (Aitman et al. 2008; Johannesson et al. 2009).
The complete sequence of the progenitor strains of these
experiments will be critical if we are to understand the
molecular basis of the phenotypes that they reveal. Simi-
larly, many labs have observed the partial penetrance of
phenotypes when knockout alleles are bred onto different
genetic backgrounds, and they are mapping these modiﬁers
(Nadeau 2003). Similarly, numerous research groups have
identiﬁed quantitative trait loci (QTLs) in mouse and rat
that they wish to deﬁne. The sequence of a wide collection
of mouse and rat strain genomes therefore will underpin the
work of large genetic screens and also efforts ongoing in
many mouse and rat labs throughout the world.
The mouse strain sequenced by the international mouse
genome sequencing consortium was C57BL/6J (Waterston
et al. 2002), which plays a central role in mouse genetics as
foundingstockforthegenerationoftransgenicandknockout
animals (Adams and van der Weyden 2008), as one of the
eight strains used in the collaborative cross (Churchill et al.
2004),asaprogenitorstrainoftheheterogeneousstockcross
(Valdar et al. 2006), and as part of the mouse phenome
project (Bogue and Grubb 2004; Bogue et al. 2007). In
addition to the sequence of C57BL/6J, there are two large
resources for the genomic sequence of inbred mouse strains.
First, four laboratory strains were included by Celera in a
whole-genome shotgun sequence of the mouse: A/J, DBA/
2J, 129X1/SvJ, and 129S1/SvImJ (Marshall 2001). The data
consist of 27.4 million capillary sequencing reads for a total
of5.39 coverage ofthemousegenome.Sequencesarefrom
both ends of size-selected 2-, 10-, and 50-kb clones derived
from randomly sheared mouse genomic DNA. Second, the
National Institute of Environmental Health Sciences con-
tracted Perlegen Sciences to resequence by hybridization 15
mouseinbredstrains(Frazeretal.2007).Thissetincludes11
classical strains (129S1/SvImJ, A/J, AKR/J, BALB/cBy,
C3H/HeJ, DBA/2J, FVB/NJ, NOD/LtJ, BTBR T
?tf/J, KK/
HlJ, and NZW/LacJ) and four strains derived from the wild
(WSB/EiJ, PWD/PhJ, CAST/EiJ, and MOLF/EiJ), which
represent the M. m. domesticus, M. m. musculus, M. m.
castaneus, and M. m. molossinus subspecies. Unlike the
Celera resource, the hybridization approach used by Perle-
gen doesnotgenerate sequence reads andcan reliably detect
only single nucleotide polymorphisms. Furthermore, the
hybridizationtechnologyusedbyPerlegenqueriedonly1.49
billion bases of the reference genome (about 58% of non-
repetitive sequence). The Perlegen approach was also found
to have a false-negative rate as high as 50% (Yang et al.
2007). Celera did not generate enough sequence of any one
strainsufﬁcientforthegenerationofadenovoassembly and
soonlyahybridassemblywasgenerated,althoughtheirdata
have proved extremely useful for nucleotide variant dis-
covery (Cunningham et al. 2006). Therefore, current
resources lack the coverage and breadth of strains to make
them a universal resource. The situation is similar for other
model organisms, where many groups have initiated pro-
grammes to proﬁle the nucleotide and structural variation
between strains using technology such as array comparative
hybridization, light shotgun sequencing, or sequencing by
hybridization. These approaches, however, all come with
compromises either because they require probes to be
designed against a reference genome and are therefore
unable to take into account novel nonreference sequence, or
becausetheyquicklybecomeprohibitivelyexpensive.Inthe
caseofhybridization-basedapproaches,therearelimitations
imposed because of genome complexity and repetitiveness.
New sequencing technologies will play a vital role in deci-
phering the complete genomes of mouse and rat strains as
well as the genomes of many other experimental organisms.
The goals for genome resequencing studies should
include the following: (1) to identify nucleotide level var-
iation between a reference and each strain, (2) to proﬁle
copy number variation between the reference and each
strain, (3) to identify sequence that is unique to each strain,
and (4) to ultimately generate complete de novo assemblies.
Signiﬁcant added value will be derived from comprehen-
sive transcriptomics and the proﬁling of transcription factor
binding sites. Collectively, these data will facilitate a sys-
tems biology approach to the study of phenotypes in model
organisms providing us with unprecedented power to
understand the genetic basis of traits. The technologies for
achieving these goals are the focus of this review.
‘‘Next-generation’’ sequencing platforms
Unlike capillary sequencing, in which a single sequencing
reaction generates a single DNA sequence, next-generation
sequencing generates hundreds of thousands of sequencing
reactionsinparallel.Thisallowsvastlyincreasedthroughput
and yield of data, enabling us to design genome-wide and
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possiblebecauseoftheirlargesize.Inthissectionwediscuss
the various technologies that are available for next-genera-
tion sequencing. A summary of the various sequencing
platforms and their throughput is shown in Table 1.
Roche 454
In 2005, the ﬁrst of the next-generation DNA sequencers,
the 454 GS20 (now Roche 454), became commercially
available (Margulies et al. 2005). The Roche 454 uses
bead-based emulsion polymerase chain reaction (em-PCR)
to amplify copies of adapter-ligated template DNA mole-
cules onto 20- or 28-lm beads, depending upon the model
of the sequencer (Dressman et al. 2003). The ratio of
template DNA to beads in the em-PCR is chosen to ensure
that the majority of ampliﬁed beads become surrounded by
amplicons derived from single template molecules. After
em-PCR, hundreds of thousands of ampliﬁed beads are
recovered and are deposited onto a PicoTiterPlate (PTP),
which is a solid surface containing wells into which single
beads can ﬁt, along with packing beads and enzyme beads.
All ampliﬁed beads on the PTP are sequenced in parallel
by pyrosequencing (Marsh 2007). In this reaction, nucle-
otides are ﬂowed sequentially, in a ﬁxed order, across the
PTP. When a nucleotide that is complementary to the
template strand ﬂows across the PTP and enters a well, the
polymerase incorporates that nucleotide, extending the
existing DNA strand. The nucleotides do not possess
blocking groups; thus, if the template strand contains two
adjacent Ts, for example, two As are incorporated into the
growing strand, so incorporation is asynchronous—strands
extend at different rates. Nucleotide incorporation is
accompanied by the release of pyrophosphate, which is
used to generate a burst of light, the intensity of which is
proportional to the number of nucleotides incorporated.
This continues for a set number of cycles, and the signal
intensity per nucleotide ﬂow is recorded for each bead over
time and is analysed to generate high-quality sequence.
In this way, throughput is increased and cost is reduced,
compared to capillary sequencing, and cloning is avoided.
The original model, the GS20, was capable of generating
20 megabases (Mb) of 100 base reads per run compared to
fewer than 100 kb for a 96-well capillary machine, and the
output has increased to several hundred megabases of 400–
500 base reads per run with the Titanium version of the
Roche 454 platform. A single Roche 454 sequencing run
can thus generate sufﬁcient data for many projects, par-
ticularly for the de novo assembly of bacterial genomes.
The major error mode with the use of pyrosequencing is
that of sequencing homopolymers. The difference in signal
intensity from the incorporation of, for example, eight of
the same nucleotide compared with seven of the same
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123nucleotide is much less than two versus one of the same
nucleotide. This is compounded by the fact that there is
some, albeit small, variation in the signal intensity between
single incorporation events. In addition, the current cost of
454 sequencing per gigabase is considerably higher than
short-read sequencing technologies, so short-read technol-
ogies tend to be used preferentially for sequencing appli-
cations that do not depend upon long reads.
Applied Biosystems’ SOLiD
The SOLiD was released in late 2007 and like the 454
relies on em-PCR to amplify fragmented DNA onto beads
clonally. After em-PCR, ampliﬁed beads are recovered and
the amplicon strands are modiﬁed at their 30 ends to allow
covalent attachment to a glass slide (Dressman et al. 2003).
However, with the SOLiD beads are considerably smaller
than with the 454, i.e., 1 lm rather than 28 lm, which
allows a higher density of beads to be packed into the same
area. The current density range is in the region of
100 million beads per sequencing run, although a large
number of these beads are not analysed because they have
more than one template ampliﬁed onto them giving a
‘‘mixed read’’ which is ﬁltered out in the analysis.
Rather than using pyrosequencing, the SOLiD platform
uses sequencing-by-ligation (Shendure et al. 2005). After
hybridization of the sequencing primer to bead-bound
amplicons, 16 random 8-mer probes are added. Probes are
labelled using one of four ﬂuorescent dyes, which are
assigned based on the nucleotides at the ﬁrst and second
positions at the 30 end of the probe. The ﬁrst and second 30
bases of one of the 16 probes will be complementary to the
template strands around a bead. This oligo ligates to the
sequencing primer and the slide is imaged. The probe is
cleaved,removingtheﬂuorescentlabelbutleavingﬁvebases
of probe ligated to the sequencing primer, and the random
probe set is added once more. Several rounds of ligation and
imaginggenerate a colour proﬁle of every ﬁfth dinucleotide.
The extended sequencing primer is removed, and a
second sequencing primer, one nucleotide shorter than the
ﬁrst, is hybridized; ligation proceeds for the same number
of rounds. The process is repeated using a total of ﬁve
sequencing primers, at the end of which a series of colours
is obtained for each bead. Because only four colours are
used and because each colour represents four dinucleotides,
it is not possible to decipher the identity of the nucleotides
without knowing the ﬁrst base in the sequence. This is
achieved by sequencing one base of the adapter.
The SOLiD is currently capable of producing approxi-
mately 20 Gb of short-read sequence data per run (25–50
bases) and so is more suited to resequencing than de novo
assembly, although optimized protocols for long-insert
read pairs up to 10 kb are available.
Illumina Genome Analyzer
Solexa sequencers ﬁrst became available for beta testing in
late 2006. They were rebranded as Illumina Genome Ana-
lyzers (GA) before their wider release following Solexa’s
takeover. Unlike the two next-generation sequencing plat-
forms described above, the GA does not rely on em-PCR to
clonally amplify template strands. Instead, adapter ligated
template molecules ﬂow into a hollow glass slide, or ﬂow
cell, at a low concentration using a ﬂuidic pumping device
termed a cluster station. The interior surfaces of the ﬂow
cells are coated with polyacrylamide to which a random
‘‘lawn’’ of forward and reverse primers is attached. Tem-
plate DNA hybridizes to the primers and is copied onto the
ﬂow-cell surface by extension of the ﬂow-cell primer to
which it hybridized. This generates a reverse complemen-
tary copy of the template strand that is covalently attached
to the ﬂow-cell surface. These newly synthesized strands
serve as templates for an isothermal ampliﬁcation reaction,
resulting in clusters of ampliﬁed strands, each of which was
derived from a single template molecule and is immobile.
Ampliﬁed clusters consist of double-stranded DNA. One
strand is selectively removed before sequencing primer
hybridization and the sequencing reaction itself, so that all
strands within each cluster are sequenced in the same
direction,fromthesameend.Theﬂowcellisthentransferred
to a Genome Analyzer, where the single-stranded clusters
undergoasequencing-by-synthesisreactionusingreversible
ﬂuorescent terminator deoxyribonucleotides (Bentley et al.
2008). Being terminator nucleotides, each DNA strand
within a cluster incorporates a single nucleotide during each
chemistry cycle, and being clonal, each strand within a
cluster incorporates the same nucleotide. Clusters are
imaged, blocking groups and ﬂuorophores on the newly
incorporated nucleotides are removed simultaneously by
chemical cleavage, and the next round of nucleotide incor-
poration begins. Sequence length is identical for all clusters
because it is governed by the number of cycles of nucleotide
incorporation, imaging, and cleavage. Images are analysed,
generating a separate sequence for each cluster.
An Illumina Genome Analyzer is currently capable of
producinganupto10-Gb‘‘purity-ﬁltered’’sequenceper76-
cycle paired-end run. Beyond this length, the frequency of
substitutionerrorscurrentlyincreasessigniﬁcantlyasaresult
of signal decay and cluster phasing and prephasing. Long
insert protocols are available, as are array- and solution-
based targeted resequencing and multiplexing protocols.
Helicos’ true single-molecule-sequencing (tSMS)
technology
Launched in 2008, Helicos’ tSMS sequencing platform is
the ﬁrst of what could be considered the next-next
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123generation (or 3rd generation) of sequencing platform and
is based on a technology that was published in 2003
(Braslavsky et al. 2003). Sequencing takes place on mil-
lions of templates in parallel, but tSMS differs from other
currently available sequencing technologies. Whereas
Illumina ampliﬁes single template molecules to make
clusters, and 454 and SOLiD use em-PCR to amplify
copies of a single template molecule onto a bead, tSMS
does not amplify templates in any way before sequencing.
As a consequence, library preparation is simple and rapid,
requiring only the addition of a poly-A tail and a ﬂuores-
cent label. Tailed template strands hybridize to poly-T
oligonucleotides on the ﬂow-cell surface, and these single
molecules are detected by their ﬂuorescent label.
Because single molecules are the substrate for the
sequencing reaction, the ﬂow cell can be packed to a very
high density, so billions of strands can potentially ﬁt onto a
single ﬂow cell. Fluorescent nucleotides are added singly.
These are not terminator nucleotides as such, but virtual
terminators that rely upon steric hindrance to deter the
incorporation of more than one nucleotide per cycle. After
incorporation the ﬂow cell is visualized to identify strands
that incorporated that particular nucleotide, the ﬂuores-
cence is removed, and the next nucleotide is added. Strands
incorporate nucleotides in an asynchronous way, the rate of
extension being governed by how the sequence of a par-
ticular template strand corresponds to the order in which
nucleotides are added. This results in sequences that differ
in length but which are typically 25–50 bases.
Sequencing single molecules avoids the problems of
phasing encountered by 454, Illumina, and SOLiD, where
somemembersofthegroupoftemplatesbeingsequenceddo
not incorporate a nucleotide at a given cycle and so lag
behind the others. There is relatively little information
available about the error rate of the tSMS platform, but it is
conceivable that sequencing single molecules causes prob-
lems with sensitivity. Reported causes of error are problems
with long homopolymers (particularly runs of poly-C) and a
high incidence of deletions. These can be reduced from 2 to
7% tobelow1% by readingthe same strand twice, but this is
achieved at the expense of doubling the running time and
increasing the length of the library prep (Harris et al. 2008).
There is currently no protocol available for performing
paired-end sequencing on the tSMS platform.
Emerging sequencing technologies
Paciﬁc Biosciences has recently showed promising early
results using single-molecule real-time DNA sequencing
(SMRT technology) (Eid et al. 2009). There are two key
underlying proprietary technologies: (1) phospholinked
nucleotides, where each nucleotide is labeled with a dif-
ferent ﬂuorophore that is attached to the c-phosphate. The
ﬂuorophore is thus removed upon incorporation of the base
by a polymerase. (2) ‘‘Zero mode waveguides’’ enable
individual molecules to be visualised without noise from
the background of unincorporated nucleotides.
The polymerase pauses as incorporation occurs, during
which time the ﬂuorophore attached to the incorporated
nucleotide becomes excited and emits ﬂuorescence. The
technology has the potential to produce very long reads at a
rate of around 10 bases per second, with thousands of
reactions proceeding in parallel. Instruments are expected
to be available in 2010.
DoverSystems’Polonatorwasannouncedearly2008and
arose from collaboration between George Church’s labora-
tory at MIT and the Danaher Corporation. Perhaps the most
appealing aspect of this platform is that it is ‘‘open source,’’
thus users are free to purchase reagents from any supplier
allowing ﬂexibility since users are not committed to using a
single sequencing chemistry, although the Polonator was
developedusingbead-basedem-PCR(Dressmanetal.2003)
and sequencing by ligation (Shendure et al. 2005).
The instrument has an excellent potential throughput
rate of approximately 3 Gb/day, though read lengths are
currently short (29 14-base paired end reads), which will
make mapping sequence reads to a vertebrate-size genome
difﬁcult. It should be inexpensive to run and currently has a
list price that is considerably lower than the other systems.
Oxford Nanopore Technologies is developing a label-
free, single-molecule sequencing technology called BASE
in which a processive exonuclease enzyme and a a-haem-
olysin nanopore are set into a lipid bilayer that lies above a
microwell (Howorka et al. 2001; Maglia et al. 2008). Many
of these wells are arrayed on a silicon chip. DNA is
digested by the exonuclease, after which the released
nucleotides pass through the nanopore. Transient binding
of nucleotides to a cyclodextrin ring within the nanopore
generates a change in the conductivity across the pore,
which is characteristic of that nucleotide.
Once commercialized, the technology will be marketed,
sold, and distributed exclusively by Illumina, which has
also made a major equity investment in the company. Other
nanopore-base sequencing technologies are being devel-
oped by NABsys and Sequenom.
Intelligent Bio-systems was founded by Jingyue Ju of
Columbia University and is based on a proprietary
sequencing-by-synthesis technology, which utilizes four
ﬂuorescent reversible terminator nucleotides (Ju et al.
2006). No instrument is available yet, but the company
claims that its technology will allow millions of sequencing
reactions to take place in parallel, with high accuracy and
speed and low cost, albeit on ampliﬁed DNA.
VisiGen Biotechnologies is developing a real-time,
single-molecule sequencing technology based on ﬂuores-
cence resonance energy transfer (FRET) between an
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123immobilized, ﬂuorescently labelled polymerase and ﬂuo-
rescent nucleotides. Massively parallel arrays of these
polymerases would allow very high sequencing rates.
More distant sequencing technologies are under devel-
opment by Affymetrix, Reveo, Base4innovation, Genome
Corp, and Complete Genomics.
Computational analysis of new technology sequencing
data
As illustrated above, next-generation sequencing technol-
ogies are capable of generating vast quantities of data, and
with impending release of next-next or third-generation
sequencing technology, the yield of data is set to skyrocket.
Next we outline the currently available computational tools
that may be used for analysis of sequencing data generated
on these platforms.
Mapping sequencing reads to the genome
By aligning short-read sequences back to a reference
genome we can detect a range of different types of
sequence variation, including single nucleotide polymor-
phisms (SNPs), short insertion/deletions (indels), and
structural and copy number variants. The single most
important task in variant discovery using short reads is to
align the individual reads (or read pairs) with the correct
location on the reference genome. The ability to map short
sequence reads to the correct location is dependent on a
number of factors such as the complexity of the reference
genome, length of the sequence reads, error rates of the
reads, and the diversity of the individual or strain compared
to the reference (Li et al. 2008).
For small genomes such as closely related bacterial
strains, the task of aligning reads is relatively easy because
even with very short sequence read lengths, a very high
proportion of the reads will align to only one location due
to the uniqueness of the reference (Fig. 1). At read lengths
of 30 bp, only 85% of the mouse reference genome is
unique enough to call high conﬁdence variants with error-
free reads. The presence of read pairs can increase the
accuracy of read alignment because ‘‘mate pair’’ informa-
tion can be used to place reads where only one of the mates
aligns with high conﬁdence to the genome (often referred
to as the mapping quality) but where the read or ‘‘mate’’ at
the other end of the sequenced molecule maps to several
possible genomic locations. One additional factor that can
decrease the accuracy of read alignment is incorrect base
calls due to sequencing errors that can result in reads being
more similar to the wrong location on the genome. To
overcome these problems, most short-read mapping pro-
grams use some combination of base quality scores,
mapping quality of the reads, and the number of reads,
calling the variant at each position in the genome to assess
the quality of a SNP call. To meet these unique challenges,
a number of new tools have been developed speciﬁcally to
align short-read sequences to genomes (Table 2).
MAQ was one of the early short-read alignment tools
(Li et al. 2008). MAQ uses a k-mer hash table approach for
indexing sequence reads and chooses the place in the
genome where the read aligns with the minimum sum of
the base qualities of the mismatched bases. This helps to
overcome the problem of erroneous base calls, making a
read more similar to the wrong location on the genome.
MAQ attempts to align all of the reads regardless of
whether they fall into repeat regions of the genome.
Clearly, this could lead to false-positive variant calls where
a read maps to multiple places equally well on the genome.
To overcome this, MAQ assigns a phred-like (Stein 2003)
mapping quality to each read alignment, which is related to
the conﬁdence in the alignment of the read. Importantly,
MAQ is very quick to map large numbers of sequence
reads. MAQ gets its speed primarily by using a hybrid
approach to aligning reads. It ﬁrst tries to match the reads
by a simple ungapped alignment and carries only a Smith-
Waterman alignment (an accurate but slow algorithm for
producing local alignments) on unmapped reads where the
mate is already mapped. Another mapping application
speciﬁcally developed for short reads is SHRiMP.
SHRiMP, developed at the University of Toronto, is a more
general-purpose alignment tool as it carries out seeded
Smith-Waterman alignments and can be used to align reads
of any length or type. However, it does not calculate
Fig. 1 The proportion of unique sequence in the Streptococcus suis
(squares) and Mus musculus (triangles) genomes for varying read
lengths. This graph indicates that read length has a critical affect on
the ability to place reads uniquely to the genome
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123mapping qualities or use paired-end information during the
alignment process, a limitation of this tool. Mosaik,
developed by Gabor Marth’s lab at Boston College, is one
of the most general-purpose short-read tools. It can align
and assemble reads generated from all sequencing plat-
forms, along with legacy Sanger reads, and importantly it is
proﬁcient at detecting short indels, an important function
lacking in other software tools.
Each of the sequencing machine vendors has also pro-
duced its own mapping tools. Newbler, from 454, is
capable of read mapping and sequence assembly. One of
the beneﬁts of 454 technology is the increased read length
compared with that of other platforms, which makes reli-
able read mapping easier. Also, Newbler is speciﬁcally
designed to handle these longer reads. ELAND is the short-
read alignment tool developed by Illumina for use with its
GA platform and is included in the processing pipeline
with the instrument. ELAND is extremely fast to run and
outputs all of the alternative places a read can be mapped
onto the genome. One drawback is that it is difﬁcult to run
ELAND independent of the Illumina GAPipeline.
Bowtie is the ﬁrst of a new generation of the short-read
aligners that use the Burrows-Wheeler transform, which is
an indexing system with a very low memory footprint
(Burrows and Wheeler 1994). Bowtie is considerably faster
than other short-read alignment tools. However, it is only
effective when the reads are extremely similar to the ref-
erence. One useful feature of Bowtie is that its output can
be imported into MAQ and hence one can utilise the var-
iant calling tools included with MAQ. This method has also
been implemented in BWA, a new developmental align-
ment tool (http://maq.sourceforge.net/bwa-man.shtml)
from the same authors as MAQ.
Single nucleotide polymorphisms
Single nucleotide polymorphisms (SNPs) are the simplest
type of sequence variation to proﬁle since in an alignment
they appear as high-quality single base differences between
sequence reads and the reference genome. A number of
papers have demonstrated very high SNP calling accuracy
from new sequencing technologies (Hillier et al. 2008;L i
et al. 2008; Wang et al. 2008). Because of the variations in
sequence quality across individual runs and across tech-
nologies, most studies use another method (e.g., genotyp-
ing) to calibrate the SNP-calling cutoffs (e.g., mapping
quality, minimum depth, cumulative base quality). For
example, Hillier et al. (2008) used the Illumina platform to
sequence a C. elegans strain and obtained a SNP validation
rate of 96.3% using PCR-targeted capillary sequencing on
a subset of the total SNPs found. When critically reviewing
claims about the accuracy of SNP detection algorithms, it
is extremely important to consider where in the genome the
test or candidate SNPs are located. SNPs located in non-
repetitive regions of the genome are generally considerably
easier to validate than SNP located in more complex
regions.
Short insertion/deletions (indels)
To detect short indels, a short-read alignment tool must be
able to carry out gapped alignments. As seen in Table 2,
the majority of short-read alignment tools have the ability
to detect short indels. Since indels are harder to validate
than SNPs, few of the indel calling algorithms have been
rigorously validated.
Table 2 A summary of short-read alignment tools
Illumina 454 SOLiD S I URL
Bowtie Y Y N Y N http://bowtie-bio.sourceforge.net
ELAND Y N N N N http://www.illumina.com
Exonerate Y Y N N Y http://www.ebi.ac.uk/*guy/exonerate/
GMAP Y N N N N http://www.gene.com/share/gmap
MOSAIK Y Y Y Y Y http://bioinformatics.bc.edu/marthlab/Mosaik
MAQ Y N Y Y Y http://maq.sourceforge.net
MUMer Y Y N Y Y http://mummer.sourceforge.net/
Novocraft Y N N Y Y http://www.novocraft.com/
RMAP Y N N N N http://rulai.cshl.edu/rmap/
SeqMap Y N N N I http://biogibbs.stanford.edu/*jiangh/SeqMap/
SHRiMP Y Y Y Y Y http://compbio.cs.toronto.edu/shrimp/
SOAP Y N N Y Y http://soap.genomics.org.cn/
SSAHA2 Y Y N Y Y http://www.sanger.ac.uk/Software
S outputs SNPs, I outputs short insertion deletions (indels)
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Almost all of the new sequencing technologies are capable
of generating paired-end reads with varying insert sizes.
Currently, the Illumina Genome Analyzer and the Roche
FLX can produce libraries with insert sizes up to 3 kb,
while the SOLiD system can generate insert sizes up to
10 kb. However, it should be noted that the exact insert
size is very library dependent and it is often necessary to
‘‘discover’’ the exact insert size of the library by aligning
the reads to the reference genome. A number of recent
studies have used insert size discrepancies to discover
high-quality structural variants (e.g., large insertions,
deletions, and inversions). Campbell et al. (2008) recently
showed how it is possible to use Illumina sequencing to
identify useful information from incorrectly aligned read
pairs to identify somatically acquired structural rear-
rangements in lung cancer. Another study used 454 paired-
end sequencing to ﬁnd structural variants (SVs) in the
human genome and was able to experimentally validate a
high number of the SVs found (Korbel et al. 2007). A
number of tools have been developed to visualize SVs. For
example, MAQ and Mosaik come with viewing applica-
tions that show the alignment of the reads on the reference
genome, allowing them to be easily visualized (Huang and
Marth 2008).
Sequence assembly
There are two main types of sequence assembly from new
sequencing technology reads. In the ﬁrst case, the reads are
mapped back to the reference genome and a consensus
sequence is generated by calling a base at each position
where reads have mapped along the reference (referred to
as a mapped assembly). This is generally not regarded as a
true de novo assembly because the resulting assembly
could be structurally biased by the reference genome.
However, this bias can be reduced by using the mate-pair
information to conﬁrm the structure of the contigs. MAQ,
Mosaik, and Newbler are capable of carrying out mapped
based assemblies.
One of the major challenges of this short-read sequenc-
ing era is the quest for software that can generate true de
novo assemblies of a vertebrate genome. The algorithmic
and computational challenges posed by this problem have
led to the development of several new assemblers (Table 3).
The huge volumes of data and the small size of the sequence
reads generated on new-technology sequencing platforms
has meant that traditional approaches of sequence assembly,
such as computing all possible read overlaps (e.g., phrap)
(Stein 2003), are not computationally feasible. Almost all of
the new assembly algorithms utilise some form of a graph
traversal approach such as the de Bruijn graph (Pevzner
et al. 2001). One measure of the performance of any
assembly algorithm is the N50. The N50 of an assembly is
the length where 50% of bases in the assembly are found in
contigs with at least this length.
Velvet is a de novo assembler based on the de Bruijn
graph approach (Zerbino and Birney 2008) and has been
used to assemble BACs with an N50 of 2 kb. Butler et al.
(2008) tested their assembler ALLPATHS by generating
simulated reads from ten ﬁnished genomes ranging from
bacteria, fungi, and a 10-Mb section of the human genome.
They achieved impressive N50s with some of the genomes
assembling into a single contig. However, the lack of real
sequence data in this study makes it difﬁcult to assess this
assembler’s true performance (Butler et al. 2008).
Most de novo assemblers perform well on bacteria and
small eukaryotes but the challenge is on to develop an
assembler that can handle a higher-vertebrate genome. At
the moment, Abyss is the only assembler capable of
assembling vertebrate-sized genomes (http://www.bcgsc.
ca/platform/bioinfo/software/abyss). It achieves this by
distributing and processing the de Bruijn graph over a
computer cluster and therefore requires considerable
computational resources. It is expected that as read lengths
Table 3 A summary of assemblers developed for use with next-generation sequencing data
Illumina 454 SOLiD D M E URL
Abyss Y N N Y N Y http://www.bcgsc.ca/platform/bioinfo/software/abyss
ALLPATHS Y N N Y N N
MAQ Y N Y N Y N http://maq.sourceforge.net
MIRA2 N Y N Y N N http://chevreux.org/projects_mira.html
Newbler N Y N Y Y N https://www.roche-applied-science.com
SSAKE Y N N Y N N http://www.bcgsc.ca/platform/bioinfo/software/ssake
SHARCGS Y N N Y N N http://sharcgs.molgen.mpg.de/
VCAKE Y N Y Y N N http://sourceforge.net/projects/vcake
Velvet Y N N Y N N http://www.ebi.ac.uk/*zerbino/velvet/
D capable of de novo assembly, M mapped assembly, E can assemble experimental organisms
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123increase, it will become more feasible to perform whole-
genome assemblies of experimental organisms.
Applications to mammalian genome sequencing
Although next-generation sequencing technology is still
novel, particularly with respect to the tool necessary to
analyse the data, strides have already been made using it. A
total of four complete diploid genomes of human individ-
uals have been sequenced to data. The ﬁrst was achieved
using traditional Sanger/capillary sequencing methods
(Levy et al. 2007). The second of these genomes was that
of the scientist James Watson, which was sequenced using
the Roche 454 technology to 7.59 genome coverage
(Wheeler et al. 2008). The reads were aligned to the NCBI
reference sequence using a combination of the BLAT and
Smith-Waterman algorithms (Wheeler et al. 2008). The
sequence differed from the reference at 3.32 Mb, of which
2.7 Mb were known differences. The sequences of the
other two human genomes, that of a Chinese individual and
an African, were done using the Illumina Genome Ana-
lyzer platform and sequenced to greater than 309 genome
coverage (Bentley et al. 2008; Wang et al. 2008). For both
genomes reads were aligned to the NCBI human reference
sequence revealing approximately 3 million SNPs. In both
cases around 74% of these SNPs were previously known.
The accuracy of these studies, as assessed by array-based
genotyping, was similar to that of the Watson Roche 454
genome. In each of the four genomes sequenced, novel
‘‘nonreference’’ sequence was discovered.
While next-generation sequencing technology has
shown itself to be useful for identifying variations between
individuals, it has also been useful for decoding novel
genomes. The latest assembly of the gorilla genome
sequence is a hybrid between sequence data derived from
traditional capillary read sequencing and next-generation
sequencing. First, the genome was sequenced to 29 gen-
ome coverage using a traditional capillary shotgun
sequencing approach, then Illumina reads were added to
facilitate the identiﬁcation of novel sequences and the
stitching together of contigs. This approach has produced a
cleaner more accurate sequence compared to other
29 coverage genomes (http://www.ensembl.org/Gorilla_
gorilla/Info/Index). Higher Illumina sequence read cover-
age is currently being generated to produce a high-quality
de novo assembly of gorilla. Another interesting applica-
tion of next-generation sequencing has been the sequencing
of nearly 3 Gb of the mammoth genome (Miller et al.
2008). Ancient DNA samples were extracted from hair
shafts, sequenced using Roche 454 technology, and aligned
to the genome of a modern elephant. It should be noted that
in all these applications, sequence generated by next-gen-
eration technology has been aligned to some reference or
scaffold generated using capillary sequence. These mapped
to reference assemblies vary greatly in there coverage and
quality and by deﬁnition are blind to most novel sequences.
Next-generation sequencing technology
as a replacement for microarrays
Since the advent of high-throughput DNA microarrays, it
has been possible to interrogate levels of thousands of
individual nucleotide species (such as transcripts or DNA
fragments recovered from CHiP experiments) simulta-
neously. In principle, most applications of microarray
technology can also be achieved using next-generation
sequencing, as the levels of any given nucleotide species
can be inferred from the number of times it is identiﬁed in a
sequencing experiment. One recent application of new
sequencing technologies, called RNA-Seq (Marioni et al.
2008; Mortazavi et al. 2008; Wang et al. 2009), directly
sequences expressed transcripts in order to directly inter-
rogate levels of transcription. The RNA is isolated from a
particular cell type and reverse transcribed, and the
resulting cDNA is subjected to next-generation sequencing.
The subsequent sequencing reads are aligned back to the
reference genome and the sequencing depth is used as the
measure of expression levels. Unlike array-based approa-
ches, RNA-Seq offers a complete and unbiased view of the
full repertoire of transcripts (Pan et al. 2008). One of the
greatest advantages is that it allows for the detection of
transcripts that are expressed at very low levels because of
the high sequencing depth that can be achieved with new
sequencing technologies. Marioni et al. (2008) found that
the method was highly replicable and had very little
technical variation across different runs of the sequencer. t
Hoen et al. (2008) found that the changes in expression
observed by deep sequencing were larger than observed by
microarrays or quantitative PCR. They were able to detect
processes such as calmodulin-dependent protein kinase
activity, vesicle transport along microtubules, and anti-
sense transcription that were not observable with an array-
based approach.
Challenges and future directions
Next-generation sequencing technologies afford many
opportunities but will also pose considerable challenges.
As indicated in this review, the major challenges of these
technologies revolve around the management and analysis
of the sequence data. Because every DNA sequencing run
on a next-generation sequencing platform generates many
gigabytes of data that must be analysed and archived,
considerable computational resources are required. At
present there are few institutions, besides the genome
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123centres, that have the computational resources, or indeed
the knowledge, to handle the amount of data that these
machines are capable of generating. This is certainly the
case for more complex tasks such as the generation of de
novo assemblies. There is likely to be an evolution in the
software tools available for analysing sequencing data, and
just as occurred with microarray analysis tools, this will
place the power of new sequencing technologies more
within reach of the average research lab and researcher. As
indicated in this review, many of the sequencing machine
vendors already provide software modules and pipelines
that facilitate some of the common sequence analysis tasks.
It is likely that the vendors will develop software to keep
pace with the development of their machines to support
read mapping, nucleotide variant calling, and the genera-
tion of de novo assemblies. The research community
should expect and demand that these software tools be
completely open source so that anyone can have access to
them.
One of the great success stories of the genome project
era was that all of the sequence data generated from these
projects was freely available, and essentially released as it
was generated. This is an expectation for all future genome
projects that the community and funding bodies should
enforce. Similarly, because it is likely that many groups
will start to generate assemblies of vertebrate genomes
using next-generation sequencing, it is important that the
standard set for the release and publication of these
assemblies be high. This can be managed in part by the free
release of sequence data, which can in turn be reanalysed
and scrutinized by the community.
Several databases have been established to collect next-
generation sequencing data. These include the Euro-
pean Short Read Archive (ERA) (www.ebi.ac.uk/embl/
Documentation/ENA-Reads.html), based at the European
Bioinformatics Institute in Cambridge, and the NIH Short
Read Archive (www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi),
based as the National Center for Biotechnology Informa-
tion, Bethesda, Maryland. These databases are likely to
face signiﬁcant challenges in the management and storage
of data from new-technology sequencing projects as pro-
jections suggest that storage and memory technology will
be pushed to the limit to accommodate all of the next-
generation sequencing data that are being generated and
which will require archiving. As sequencing read lengths
are increasing dramatically and read numbers appear to
also be increasing on most platforms, these data manage-
ment and storage issues will require signiﬁcant investments
in computational infrastructure; this will have signiﬁcant
ﬁnancial implications.
For mouse and rat genetics, it is a golden age. Within the
next few years it is likely that we will have high-quality
assemblies for many of the strains that are commonly used
in our research laboratories. The sequence of these strains
will ﬁnally allow us to gain a complete picture of the
genetic variation between strains, and will greatly facilitate
the identiﬁcation of the causal variants responsible for the
QTLs and modiﬁer alleles that many of us have spent years
mapping. It is also likely that there will be a renaissance in
techniques such as the use of N-ethyl-N-nitrosourea (ENU)
(Justice 2000; Kile et al. 2003) and other mutagens for
forward genetic screens. When we reach the point of the
$1,000 genome for mouse and rat, touted as a looming
landmark in human genetics, ﬁnding causal nucleotide
variants from mutagenesis screens in the mouse will no
longer be the challenge that it currently is. Indeed, in yeast
and C. elegans next-generation sequencing technologies
are resulting in the demise of positional cloning-based
approaches because it is now considerably easier to just
resequence the entire genome of the mutant yeast or worm
rather than map the mutation (Hillier et al. 2008; Schach-
erer et al. 2007). The same will soon be the case for ver-
tebrate experimental organisms such as mouse and rat.
One thing that is clear is that in the future, when we look
back on this era of new-sequencing technology develop-
ment, we will wonder how we ever lived without it.
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